Bisphenol A exposure increases liver fat in juvenile fructose-fed Fischer 344 rats

Toxicology

Volumn 303, Issue , 2013, Pages 125-132

  Rönn, Monika ^a   Kullberg, Joel ^a   Karlsson, Helen ^b   Berglund, Johan ^a   Malmberg, Filip ^a   Örberg, Jan ^a   Lind, Lars ^a   Ahlström, Håkan ^a   Lind, P Monica ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Bisphenol A; Liver fat; MRI; Obesity; Rat

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; APOLIPOPROTEIN A; DRINKING WATER; FRUCTOSE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FATTY LIVER; FEMALE; INTRAABDOMINAL FAT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ADIPOSE TISSUE; ANIMALS; APOLIPOPROTEIN A-I; BENZHYDRYL COMPOUNDS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; FEMALE; FRUCTOSE; INTRA-ABDOMINAL FAT; LIVER; MAGNETIC RESONANCE IMAGING; OBESITY; PHENOLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, INBRED F344;

RATTUS; RODENTIA;

EID: 84870923449     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2012.09.013     Document Type: Article

References (53)

1. Barker D.J., Eriksson J.G., Forsen T., Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int. J. Epidemiol. 2002, 31:1235-1239.
2. Berglund J., Ahlström H., Johansson L., Kullberg J. Single-Image Water-Fat separation 2010, International Society for Magnetic Resonance in Medicine, Stockholm.
3. Berglund J., Kullberg J. Three-dimensional water/fat separation and T 2* estimation based on whole-image optimization - application in breathhold liver imaging at 1.5T. Magn. Reson. Med. 2012, 67:1684-1693.
4. Bocarsly M.E., Powell E.S., Avena N.M., Hoebel B.G. High-fructose corn syrup causes characteristics of obesity in rats: increased body weight, body fat and triglyceride levels. Pharmacol. Biochem. Behav. 2010, 97:101-106.
5. Bremer A.A., Mietus-Snyder M., Lustig R.H. Toward a unifying hypothesis of metabolic syndrome. Pediatrics 2012, 129:557-570.
6. Choi J.H., Banks A.S., Estall J.L., Kajimura S., Bostrom P., Laznik D., Ruas J.L., Chalmers M.J., Kamenecka T.M., Bluher M., Griffin P.R., Spiegelman B.M. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR[ggr] by Cdk5. Nature 2010, 466:451-456.
7. Dodds L. Synthetic oestrogenic agents without the phenanthrene nucleus. Nature 1936, 137.
8. Duvillard L., Dautin G., Florentin E., Jeannin A., Pais de Barros J.P., Lagrost L., Petit J.M., Gambert P., Verges B. Increased apolipoprotein AI production rate and redistribution of high-density lipoprotein size induced by estrogen plus progestin as oral contraceptive. J. Clin. Endocrinol. Metab. 2009, 94:4891-4897.
9. Ema M., Fujii S., Furukawa M., Kiguchi M., Ikka T., Harazono A. Rat two-generation reproductive toxicity study of bisphenol A. Reprod. Toxicol. 2001, 15:505-523.
10. Eriksson J.W., Jansson P.A., Carlberg B., Hagg A., Kurland L., Svensson M.K., Ahlstrom H., Strom C., Lonn L., Ojbrandt K., Johansson L., Lind L. Hydrochlorothiazide, but not Candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: the mechanisms for the diabetes preventing effect of Candesartan (MEDICA) Study. Hypertension 2008, 52:1030-1037.
11. Felzenszwalb P.F., Huttenlocher D.P. Efficient belief propagation for early vision. Int. J. Computer Vis. 2006, 70:41-54.
12. Flegal K.M., Carroll M.D., Kit B.K., Ogden C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults 1999-2010. JAMA 2012, 307:491-497.
13. Ginsberg G., Rice D.C. Does rapid metabolism ensure negligible risk from bisphenol A?. Environ. Health Perspect. 2009, 117.
14. Grun F., Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006, 147:S50-S55.
15. Hamilton G., Yokoo T., Bydder M., Cruite I., Schroeder M.E., Sirlin C.B., Middleton M.S. In vivo characterization of the liver fat (1)H MR spectrum. NMR Biomed. 2011, 24(7):784-790.
16. Henning M.F., Herlax V., Bakas L. Contribution of the C-terminal end of apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect. Innate Immun. 2011, 17:327-337.
17. Izzotti A., Kanitz S., D'Agostini F., Camoirano A., De Flora S. Formation of adducts by bisphenol A, an endocrine disruptor, in DNA in vitro and in liver and mammary tissue of mice. Mutat. Res./Genet. Toxicol. Environ. Mutagen. 2009, 679:28-32.
18. Jaichander P., Selvarajan K., Garelnabi M., Parthasarathy S. Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin. J. Lipid Res. 2008, 49:2142-2148.
19. Janesick A., Blumberg B. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res. C Embryo Today 2011, 93:34-50.
20. Jensen M.N., Ritskes-Hoitinga M. How isoflavone levels in common rodent diets can interfere with the value of animal models and with experimental results. Lab. Anim. 2007, 41:1-18.
21. Karlsson H., Ljunggren S., Ahren M., Ghafouri B., Uvdal K., Lindahl M., Ljungman A. Two-dimensional gel electrophoresis and mass spectrometry in studies of nanoparticle-protein interactions. Gel Electrophoresis 2012, Tech, Rijeka, Croatia. S. Magdeldin (Ed.).
22. Koo H.-Y., Wallig M.A., Chung B.H., Nara T.Y., Cho B.H.S., Nakamura M.T. Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver. Biochim. Biophys. Acta (BBA): Mol. Basis Dis. 2008, 1782:341-348.
23. Kwintkiewicz J., Nishi Y., Yanase T., Giudice L.C. Peroxisome proliferator-activated receptor-gamma mediates bisphenol A inhibition of FSH-stimulated IGF-1, aromatase, and estradiol in human granulosa cells. Environ. Health Perspect. 2010, 118:400-406.
24. LaKind J.S., Levesque J., Dumas P., Bryan S., Clarke J., Naiman D.Q. Comparing United States and Canadian population exposures from National Biomonitoring Surveys: Bisphenol A intake as a case study. J. Expos. Sci. Environ. Epidemiol. 2011, 21(3):272-279.
25. Lee D.H., Steffes M.W., Sjodin A., Jones R.S., Needham L.L., Jacobs D.R. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One 2011, 6:e15977.
26. Liew A.W.-C., Yan H., Law N.F. Image segmentation based on adaptive cluster prototype estimation. IEEE Trans. Fuzzy Syst. 2005, 13:444-453.
27. Lustig R.H. Fructose: metabolic, hedonic, and societal parallels with ethanol. J. Am. Diet. Assoc. 2010, 110:1307-1321.
28. Malmberg F., Lindblad J., Nyström I. Sub-pixel segmentation with the image foresting transform. International Workshop on Combinatorial Image Analysis (IWCIA) 2009, 201-211. Springer, Mexico. P. Wiederhold, R.P. Barneva (Eds.).
29. Marmugi A., Ducheix S., Lasserre F., Polizzi A., Paris A., Priymenko N., Bertrand-Michel J., Pineau T., Guillou H., Martin P.G.P., Mselli-Lakhal L. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 2012, 55:395-407.
30. Miyawaki J., Sakayama K., Kato H., Yamamoto H., Masuno H. Perinatal and postnatal exposure to bisphenol A increases adipose tissue mass and serum cholesterol level in mice. J. Atheroscler. Thromb. 2007, 14:245-252.
31. Moon M.K., Kim M.J., Jung I.K., Koo Y.D., Ann H.Y., Lee K.J., Kim S.H., Yoon Y.C., Cho B.J., Park K.S., Jang H.C., Park Y.J. Bisphenol A impairs mitochondrial function in the liver at doses below the no observed adverse effect level. J. Korean Med. Sci. 2012, 27:644-652.
32. Odum J., Tinwell H., Jones K., Van Miller J.P., Joiner R.L., Tobin G., Kawasaki H., Deghenghi R., Ashby J. Effect of rodent diets on the sexual development of the rat. Toxicol. Sci. 2001, 61:115-127.
33. Olsen L., Lampa E., Birkholz D.A., Lind L., Lind P.M. Circulating levels of bisphenol A (BPA) and phthalates in an elderly population in Sweden, based on the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS). Ecotoxicol. Environ. Saf. 2012, 75:242-248.
34. Phrakonkham P., Viengchareun S., Belloir C., Lombès M., Artur Y., Canivenc-Lavier M.-C. Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis. J. Steroid Biochem. Mol. Biol. 2008, 110:95-103.
35. Pottenger L.H., Domoradzki J.Y., Markham D.A., Hansen S.C., Cagen S.Z., Waechter J.M. The relative bioavailability and metabolism of bisphenol A in rats is dependent upon the route of administration. Toxicol. Sci. 2000, 54:3-18.
36. Rhomberg L.R., Goodman J.E. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made?. Regul. Toxicol. Pharm. 2012, 64:130-133.
37. Richter C.A., Birnbaum L.S., Farabollini F., Newbold R.R., Rubin B.S., Talsness C.E., Vandenbergh J.G., Walser-Kuntz D.R., vom Saal F.S. In vivo effects of bisphenol A in laboratory rodent studies. Reprod. Toxicol. 2007, 24:199-224.
38. Rubin B.S., Murray M.K., Damassa D.A., King J.C., Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health Perspect. 2001, 109:675-680.
39. Ruzzin J., Petersen R., Meugnier E., Madsen L., Lock E.J., Lillefosse H., Ma T., Pesenti S., Sonne S.B., Marstrand T.T., Malde M.K., Du Z.Y., Chavey C., Fajas L., Lundebye A.K., Brand C.L., Vidal H., Kristiansen K., Froyland L. Persistent organic pollutant exposure leads to insulin resistance syndrome. Environ. Health Perspect. 2010, 118:465-471.
40. Ryan K.K., Haller A.M., Sorrell J.E., Woods S.C., Jandacek R.J., Seeley R.J. Perinatal exposure to bisphenol-A and the development of metabolic syndrome in CD-1 mice. Endocrinology 2010, 151:2603-2612.
41. Smoak K.A., Aloor J.J., Madenspacher J., Merrick B.A., Collins J.B., Zhu X., Cavigiolio G., Oda M.N., Parks J.S., Fessler M.B. Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation. Cell Metab. 2010, 11:493-502.
42. Snyder R.W., Maness S.C., Gaido K.W., Welsch F., Sumner S.C.J., Fennell T.R. Metabolism and disposition of bisphenol A in female rats. Toxicol. Appl. Pharmacol. 2000, 168:225-234.
43. Somm E., Schwitzgebel V.M., Toulotte A., Cederroth C.R., Combescure C., Nef S., Aubert M.L., Huppi P.S. Perinatal exposure to bisphenol A alters early adipogenesis in the rat. Environ. Health Perspect. 2009, 117:1549-1555.
44. Soriano S., Alonso-Magdalena P., Garcia-Arevalo M., Novials A., Muhammed S.J., Salehi A., Gustafsson J.A., Quesada I., Nadal A. Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor beta. PLoS One 2012, 7:e31109.
45. Tominaga T., Negishi T., Hirooka H., Miyachi A., Inoue A., Hayasaka I., Yoshikawa Y. Toxicokinetics of bisphenol A in rats, monkeys and chimpanzees by the LC-MS/MS method. Toxicology 2006, 226:208-217.
46. Tyl R.W., Myers C.B., Marr M.C., Sloan C.S., Castillo N.P., Veselica M.M., Seely J.C., Dimond S.S., Van Miller J.P., Shiotsuka R.N., Beyer D., Hentges S.G., Waechter J.M. Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice. Toxicol. Sci. 2008, 104:362-384.
47. Tyl R.W., Myers C.B., Marr M.C., Thomas B.F., Keimowitz A.R., Brine D.R., Veselica M.M., Fail P.A., Chang T.Y., Seely J.C., Joiner R.L., Butala J.H., Dimond S.S., Cagen S.Z., Shiotsuka R.N., Stropp G.D., Waechter J.M. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol. Sci. 2002, 68:121-146.
48. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.-H., Shioda T., Soto A.M., vom Saal F.S., Welshons W.V., Zoeller R.T., Myers J.P. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 2012, 33:378-455.
49. Wei J., Lin Y., Li Y., Ying C., Chen J., Song L., Zhou Z., Lv Z., Xia W., Chen X., Xu S. Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology 2011, 152:3049-3061.
50. Völkel W., Colnot T., Csanády G.A., Filser J.G., Dekant W. Metabolism and kinetics of bisphenol A in humans at low doses following oral administration. Chem. Res. Toxicol. 2002, 15:1281-1287.
51. Yamashita U., Sugiura T., Yoshida Y., Kuroda E. Effect of endocrine disrupters on macrophage functions in vitro. J. UOEH 2005, 27:1-10.
52. Yilmaz Y. Review article: fructose in non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2012, 35:1135-1144.
53. Yu B.L., Wang S.H., Peng D.Q., Zhao S.P. HDL and immunomodulation: an emerging role of HDL against atherosclerosis. Immunol. Cell Biol. 2010, 88:285-290.